Crossmark Global Holdings’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,553
| Closed | -$390K | – | 1347 |
|
|
2023
Q4 | $390K | Sell |
11,553
-534
| -4% | -$18K | 0.01% | 944 |
|
|
2023
Q3 | $380K | Buy |
12,087
+476
| +4% | +$15K | 0.01% | 916 |
|
|
2023
Q2 | $415K | Sell |
11,611
-49
| -0.4% | -$1.75K | 0.01% | 930 |
|
|
2023
Q1 | $476K | Buy |
11,660
+1,404
| +14% | +$57.3K | 0.01% | 850 |
|
|
2022
Q4 | $396K | Buy |
10,256
+594
| +6% | +$22.9K | 0.01% | 894 |
|
|
2022
Q3 | $514K | Sell |
9,662
-191
| -2% | -$10.2K | 0.01% | 764 |
|
|
2022
Q2 | $575K | Sell |
9,853
-50
| -0.5% | -$2.92K | 0.01% | 762 |
|
|
2022
Q1 | $756K | Buy |
9,903
+5,283
| +114% | +$403K | 0.02% | 726 |
|
|
2021
Q4 | $278K | Sell |
4,620
-5,590
| -55% | -$336K | 0.01% | 1184 |
|
|
2021
Q3 | $572K | Sell |
10,210
-90
| -0.9% | -$5.04K | 0.01% | 854 |
|
|
2021
Q2 | $625K | Sell |
10,300
-170
| -2% | -$10.3K | 0.01% | 805 |
|
|
2021
Q1 | $734K | Buy |
10,470
+190
| +2% | +$13.3K | 0.02% | 719 |
|
|
2020
Q4 | $615K | Buy |
10,280
+5,910
| +135% | +$354K | 0.02% | 757 |
|
|
2020
Q3 | $263K | Buy |
4,370
+170
| +4% | +$10.2K | 0.01% | 1091 |
|
|
2020
Q2 | $220K | Buy |
+4,200
| New | +$220K | 0.01% | 1191 |
|